Deze keuzehulp is gebaseerd op de papieren keuzehulp ‘Keuzehulp voor mannen met gelokaliseerde prostaatkanker’.
De informatie in deze keuzehulp is gebaseerd op de Europese richtlijn Prostaatkanker (versie 2022) en de richtlijn Prostaatkanker (versie 2014–2019) van de Nederlandse Vereniging voor Urologie (NVU).
Ook zijn de volgende bronnen gebruikt:
- Bryant RJ, Oxley J, Young GJ, et al. The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression. BJU Int 2020;125:506-514. Hier te vinden
- Klotz L, Vesprini D, Sethukavalan P, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 2015;33:272-277. Hier te vinden
- Vernooij RW, Lancee M, Cleves A, et al. Radical prostatectomy versus deferred treatment for localised prostate cancer. Cochrane Datab Syst Rev 2020;6:CD006590. Hier te vinden
- Klotz L, Zhang L, Lam A, et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010;28:126-131. Hier te vinden
- Nicolai M, Urkmez A, Sarikaya S, et al. Penile rehabilitation and treatment options for erectile dysfunction following radical prostatectomy and radiotherapy: a systematic review. Front Surg 2021;8:636974. Hier te vinden
- Schauer I, Keller E, Muller A, Madersbacher S. Have rates of erectile dysfunction improved within the past 17 years after radical prostatectomy? A systematic analysis of the control arms of prospective randomized trials on penile rehabilitation. Andrology 2015;3:661-665. Hier te vinden
- Briganti A, Capitanio U, Chun FK, et al. Prediction of sexual function after radical prostatectomy. Cancer 2009;115:3150-3159. Hier te vinden
- Roscher P, Sathiram R, Milios JE, van Wyk JM. Mapping the prevalence and use of questionnaires to detect the neglected sexual side effects after prostate cancer treatment: a scoping review. Syst Rev 2022;11:2. Hier te vinden
- Hamdy FC, Donovan JL, Lane JA, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 2016;375:1415-1424. Hier te vinden
- Chen C, Chen Z, Wang K, et al. Comparisons of health-related quality of life among surgery and radiotherapy for localized prostate cancer: a systematic review and meta-analysis. Oncotarget 2017;8:99057-99065. Hier te vinden
- Wilt TJ, MacDonald R, Rutks I, et al. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008;148:435-448. Hier te vinden
- King MT, Keyes M, Frank SJ, et al. Low dose rate brachytherapy for primary treatment of localized prostate cancer: a systematic review and executive summary of an evidence-based consensus statement. Brachyther 2021;20:1114-1129. Hier te vinden
- Koukourakis G, Kelekis N, Armonis V, Kouloulias V. Brachytherapy for prostate cancer: a systematic review. Adv Urol 2009;2009:327945. Hier te vinden